| 会展描述 |
描Overview and Purpose
The 10th International Congress on the Future of Breast Cancer is an educational and scientific meeting that focuses on the clinical implications of breast cancer genetic and phenotypic subtyping, as well as novel agents and strategies changing the future of breast cancer therapy. New data and promising studies that provide information about how to optimally individualize breast cancer therapy will be discussed, and controversial issues will be debated. The conference provides a unique opportunity for medical, surgical and radiation oncologists and other healthcare professionals to learn from and interact with international leaders in breast cancer in order to increase knowledge, apply new data to practice, and ultimately improve patient outcomes.
Target Audience
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
Determine optimal surgical care for patients with breast cancer
Describe recent advances in radiation therapy in the treatment of patients with breast cancer
Identify the roles of biomarkers, genomic assays, and other risk assessment tools in treatment decision-making for breast cancer
Summarize optimal strategies for endocrine therapy and management of bone health for patients with hormone receptor–positive breast cancer
Identify appropriate strategies for the use of cytotoxic agents in the treatment of patients with early–stage and advanced/refractory breast cancer
Design treatment strategies for patients with HER2–overexpressing breast cancer, including novel agents, combination regimens, and options for patients who progress on standard therapy Utilize targeted agents in the treatment of HER2– breast cancer
Select eligible patients with breast cancer for promising clinical trials
概况和目的
十周年开个晚会的国际会议,乳腺癌的未来是一个教育与科研会议关注乳腺癌的临床意义各种类型遗传表现,以及小说改变未来的代理和策略乳腺癌的治疗。研究表明,新的数据和承诺提供有关如何最佳乳腺癌个体化的治疗将有争议的问题进行了讨论,并将讨论的热点。会议提供了一个独特的机会医疗、手术和放射肿瘤医生和其他保健专业人员学习和相互作用,国际领导人在乳腺癌为了增加知识,运用新的数据到实践,最终改善病人预后。
目标受众
这种教育计划是朝向医疗、手术、放射肿瘤学家感兴趣的治疗乳腺癌。研究员,护理人员、护士、医生助理、研究人员和其他专业医护人员感兴趣的乳腺癌的治疗也邀请参加。
学习目标
在完成这次教育活动,参加者应该能够:
确定最佳手术关心病人患了乳癌
描述了近年来在放射疗法治疗病人的乳腺癌
识别标记基因的作用、化验费、和其他风险评估工具对乳腺癌的治疗决策
总结为内分泌治疗的最优策略和管理患者骨健康的激素受体阳性的乳腺癌
确定合适的策略使用药物毒性治疗病人的早期和先进/耐火乳腺癌
设计的治疗策略HER2-乳腺癌患者,包括小说、代理商、联合用药及期权标准治疗的患者进展利用靶向药物治疗HER2 -乳腺癌
选择合格的乳腺癌患者为有前途的临床试验
|
